RAN nucleo-cytoplasmic transport and mitotic spindle assembly partners XPO7 and TPX2 are new prognostic biomarkers in serous epithelial ovarian cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Cáceres Gorriti, Katia Y ^a,b   Carmona, Euridice ^a,b   Barrès, Véronique ^a,b   Rahimi, Kurosh ^a   Létourneau, Isabelle J ^a,b   Tonin, Patricia N ^c,d   Provencher, Diane ^a,b,e   Mes Masson, Anne Marie ^a,b,e  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Institut du Cancer de Montreal   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; EXPORTIN 7; RAN PROTEIN; REGULATOR PROTEIN; TARGETING PROTEIN FOR XKLP2; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; KARYOPHERIN; MICROTUBULE ASSOCIATED PROTEIN; NUCLEAR PROTEIN; RAN PROTEIN, HUMAN; TPX2 PROTEIN, HUMAN; TUMOR MARKER; XPO7 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS SPINDLE; NUCLEOCYTOPLASMIC TRANSPORT; OVARY CARCINOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; VERY ELDERLY; ACTIVE TRANSPORT; CELL NUCLEUS; CYTOPLASM; GENE EXPRESSION REGULATION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; NEOPLASM; OVARY TUMOR; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SPINDLE APPARATUS; TISSUE MICROARRAY; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; KARYOPHERINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RAN GTP-BINDING PROTEIN; SPINDLE APPARATUS; TISSUE ARRAY ANALYSIS;

EID: 84898728131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091000     Document Type: Article

References (50)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Colombo N, Van Gorp T, Parma G, Amant F, Gatta G, et al. (2006) Ovarian cancer. Crit Rev Oncol Hematol 60: 159-179. (Pubitemid 44636248)
3. Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19: 3-10. (Pubitemid 30439309)
4. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, et al. (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377: 127-138.
5. McGuire WP (2009) Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates. J Clin Oncol 27: 4633-4634.
6. Chen VW, Ruiz B, Killeen JL, Cote TR, Wu XC, et al. (2003) Pathology and classification of ovarian tumors. Cancer 97: 2631-2642. (Pubitemid 36539064)
7. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22: 255-288. (Pubitemid 32458162)
8. de Souza PL, Friedlander ML (1992) Prognostic factors in ovarian cancer. Hematol Oncol Clin North Am 6: 761-782.
9. Malpica A (2008) Grading of ovarian cancer: a histotype-specific approach. Int J Gynecol Pathol 27: 175-181.
10. Singer G, Kurman RJ, Chang HW, Cho SK, Shih Ie M (2002) Diverse tumorigenic pathways in ovarian serous carcinoma. Am J Pathol 160: 1223-1228. (Pubitemid 34411626)
11. Seidman JD, Kurman RJ (2000) Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 31: 539-557. (Pubitemid 30323979)
12. Ouellet V, Provencher DM, Maugard CM, Le Page C, Ren F, et al. (2005) Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling. Oncogene 24: 4672-4687. (Pubitemid 41032604)
13. Ouellet V, Guyot MC, Le Page C, Filali-Mouhim A, Lussier C, et al. (2006) Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int J Cancer 119: 599-607. (Pubitemid 43955714)
14. Barres V, Ouellet V, Lafontaine J, Tonin PN, Provencher DM, et al. (2010) An essential role for Ran GTPase in epithelial ovarian cancer cell survival. Mol Cancer 9: 272.
15. Fan H, Lu Y, Qin H, Zhou Y, Gu Y, et al. (2012) High Ran level is correlated with poor prognosis in patients with colorectal cancer. Int J Clin Oncol.
16. Woo IS, Jang HS, Eun SY, Kim HJ, Ham SA, et al. (2008) Ran suppresses paclitaxel-induced apoptosis in human glioblastoma cells. Apoptosis 13: 1223-1231.
17. Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, et al. (2004) Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients. Clin Cancer Res 10: 6695-6702. (Pubitemid 39346567)
18. Xia F, Lee CW, Altieri DC (2008) Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res 68: 1826-1833. (Pubitemid 351416568)
19. Li H, Ren CP, Tan XJ, Yang XY, Zhang HB, et al. (2006) Identification of genes related to nasopharyngeal carcinoma with the help of pathway-based networks. Acta Biochim Biophys Sin (Shanghai) 38: 900-910. (Pubitemid 44952893)
20. Sorokin AV, Kim ER, Ovchinnikov LP (2007) Nucleocytoplasmic transport of proteins. Biochemistry (Mosc) 72: 1439-1457.
21. Stewart M (2007) Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol 8: 195-208.
22. Clarke PR, Zhang C (2008) Spatial and temporal coordination of mitosis by Ran GTPase. Nat Rev Mol Cell Biol 9: 464-477. (Pubitemid 351733403)
23. Ohtsubo M, Okazaki H, Nishimoto T (1989) The RCC1 protein, a regulator for the onset of chromosome condensation locates in the nucleus and binds to DNA. J Cell Biol 109: 1389-1397. (Pubitemid 19251198)
24. Bischoff FR, Krebber H, Smirnova E, Dong W, Ponstingl H (1995) Co-activation of RanGTPase and inhibition of GTP dissociation by Ran-GTP binding protein RanBP1. EMBO J 14: 705-715.
25. Matunis MJ, Coutavas E, Blobel G (1996) A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J Cell Biol 135: 1457-1470. (Pubitemid 26427644)
26. Mahajan R, Delphin C, Guan T, Gerace L, Melchior F (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97-107. (Pubitemid 27180334)
27. Kalab P, Weis K, Heald R (2002) Visualization of a Ran-GTP gradient in interphase and mitotic Xenopus egg extracts. Science 295: 2452-2456. (Pubitemid 34270259)
28. Arts GJ, Fornerod M, Mattaj IW (1998) Identification of a nuclear export receptor for tRNA. Curr Biol 8: 305-314. (Pubitemid 28159116)
29. Kutay U, Lipowsky G, Izaurralde E, Bischoff FR, Schwarzmaier P, et al. (1998) Identification of a tRNA-specific nuclear export receptor. Mol Cell 1: 359-369. (Pubitemid 128378884)
30. Koch P, Bohlmann I, Schafer M, Hansen-Hagge TE, Kiyoi H, et al. (2000) Identification of a novel putative Ran-binding protein and its close homologue. Biochem Biophys Res Commun 278: 241-249.
31. Kutay U, Hartmann E, Treichel N, Calado A, Carmo-Fonseca M, et al. (2000) Identification of two novel RanGTP-binding proteins belonging to the importin beta superfamily. J Biol Chem 275: 40163-40168. (Pubitemid 32064644)
32. Macara IG (2001) Transport into and out of the nucleus. Microbiol Mol Biol Rev 65: 570-594, table of contents.
33. Strom AC, Weis K (2001) Importin-beta-like nuclear transport receptors. Genome Biol 2: REVIEWS3008.
34. Dasso M (2001) Running on Ran: nuclear transport and the mitotic spindle. Cell 104: 321-324.
35. Gruss OJ, Carazo-Salas RE, Schatz CA, Guarguaglini G, Kast J, et al. (2001) Ran induces spindle assembly by reversing the inhibitory effect of importin alpha on TPX2 activity. Cell 104: 83-93. (Pubitemid 32144974)
36. Rensen WM, Mangiacasale R, Ciciarello M, Lavia P (2008) The GTPase Ran: regulation of cell life and potential roles in cell transformation. Front Biosci 13: 4097-4121. (Pubitemid 351611596)
37. Dorfman J, Macara IG (2008) STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell 19: 1614-1626. (Pubitemid 351805114)
38. Mingot JM, Bohnsack MT, Jakle U, Gorlich D (2004) Exportin 7 defines a novel general nuclear export pathway. EMBO J 23: 3227-3236. (Pubitemid 39209147)
39. Aguirre-Portoles C, Bird AW, Hyman A, Canamero M, Perez de Castro I, et al. (2012) Tpx2 controls spindle integrity, genome stability, and tumor development. Cancer Res 72: 1518-1528.
40. Winter SF, Lukes L, Walker RC, Welch DR, Hunter KW (2012) Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. PLoS Genet 8: e1002735.
41. Gruss OJ, Wittmann M, Yokoyama H, Pepperkok R, Kufer T, et al. (2002) Chromosome-induced microtubule assembly mediated by TPX2 is required for spindle formation in HeLa cells. Nat Cell Biol 4: 871-879. (Pubitemid 35331362)
42. Ma Y, Lin D, Sun W, Xiao T, Yuan J, et al. (2006) Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer. Clin Cancer Res 12: 1121-1127. (Pubitemid 43342499)
43. Vainio P, Mpindi JP, Kohonen P, Fey V, Mirtti T, et al. (2012) High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer. PLoS One 7: e39801.
44. Etemadmoghadam D, George J, Cowin PA, Cullinane C, Kansara M, et al. (2010) Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer. PLoS One 5: e15498.
45. Ramakrishna M, Williams LH, Boyle SE, Bearfoot JL, Sridhar A, et al. (2010) Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis. PLoS One 5: e9983.
46. Roscioli E, Bolognesi A, Guarguaglini G, Lavia P (2010) Ran control of mitosis in human cells: gradients and local signals. Biochem Soc Trans 38: 1709-1714.
47. Scharer CD, Laycock N, Osunkoya AO, Logani S, McDonald JF, et al. (2008) Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. J Transl Med 6: 79.
48. Weaver BA, Cleveland DW (2005) Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 8: 7-12. (Pubitemid 40991810)
49. Kurisetty VV, Johnston PG, Johnston N, Erwin P, Crowe P, et al. (2008) RAN GTPase is an effector of the invasive/metastatic phenotype induced by osteopontin. Oncogene 27: 7139-7149.
50. Ly TK, Wang J, Pereira R, Rojas KS, Peng X, et al. (2010) Activation of the Ran GTPase is subject to growth factor regulation and can give rise to cellular transformation. J Biol Chem 285: 5815-5826.